Nick Pizzie, CHIEF FINANCIAL OFFICER at Axsome Therapeutics, Inc. (AXSM), bought 955 shares at $35.50 ($34K) on 2021-11-18, disclosed to the SEC on 2021-11-22.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $34.30 | 145 | $5K | 14.8% |
| 2 | $35.20 | 142 | $5K | 14.8% |
| 3 | $35.43 | 141 | $5K | 14.8% |
| 4 | $35.50 | 527 | $19K | 55.6% |
| Total | $35.26 avg | 955 | $34K | 100% |
| Filing → |
| AXSM | SELL | 2025-02-14 | $3.5M | — | Filing → |
| AXSM | BUY | 2020-06-30 | $119K | — | Filing → |
| AXSM | BUY | 2019-09-30 | $54K | — | Filing → |